Brock University

Canadian Study to Evaluate Outcomes of Personalized Medical Cannabis Treatment

7 months ago

• Santé Cannabis is recruiting 3,000 patients for a 3-year study to assess the outcomes of personalized medical cannabis treatment plans. • The study will evaluate benefits, safety risks, medication substitution, and cost analysis over a 12-month period. • Researchers aim to address unanswered clinical questions regarding the therapeutic use of medical cannabis, including newer products and cannabinoid formulations. • The project is supported by grants from industry partners Aurora Cannabis, Tilray Medical, and Vectura Fertin Pharma.